Get started
Biora Therapeutics, Inc.Biora Therapeutics, Inc.Biora Therapeutics, Inc.

Biora Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

BIOR chart


Full chart

BIOR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.33 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−10.87 USD
Net income (FY)
‪−124.11 M‬ USD
Revenue (FY)
‪4.00 K‬ USD
Shares float
‪4.37 M‬
Beta (1Y)
1.52

Employees


Employees (FY)
58
Change (1Y)
+4 +7.41%
Revenue / Employee (1Y)
68.97 USD
Net income / Employee (1Y)
‪−2.14 M‬ USD

About Biora Therapeutics, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Aditya P. Mohanty
Website
bioratherapeutics.com
Headquarters
San Diego
Founded
2010
FIGI
BBG007K8X5S6
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BIOR news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

BIOR highest yielding bonds


PROG5323271
Biora Therapeutics, Inc. 7.25% 01-DEC-2025
Yield to maturity
48.38%
Maturity date
Dec 1, 2025

Explore more bonds 

Frequently Asked Questions


The current price of BIOR is 1.62 USD — it has decreased by −0.61% in the past 24 hours. Watch Biora Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biora Therapeutics, Inc. stocks are traded under the ticker BIOR.
BIOR stock has fallen by −40.00% compared to the previous week, the month change is a −62.41% fall, over the last year Biora Therapeutics, Inc. has showed a −88.09% decrease.
We've gathered analysts' opinions on Biora Therapeutics, Inc. future price: according to them, BIOR price has a max estimate of 45.00 USD and a min estimate of 23.00 USD. Watch BIOR chart and read a more detailed Biora Therapeutics, Inc. stock forecast: see what analysts think of Biora Therapeutics, Inc. and suggest that you do with its stocks.
BIOR reached its all-time high on Jun 19, 2020 with the price of 3,980.00 USD, and its all-time low was 2.03 USD and was reached on Nov 15, 2024. View more price dynamics on BIOR chart.
See other stocks reaching their highest and lowest prices.
BIOR stock is 18.88% volatile and has beta coefficient of 1.52. Track Biora Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Biora Therapeutics, Inc. there?
Today Biora Therapeutics, Inc. has the market capitalization of ‪7.33 M‬, it has decreased by −34.54% over the last week.
Yes, you can track Biora Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Biora Therapeutics, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOR earnings for the last quarter are −6.08 USD per share, whereas the estimation was −3.85 USD resulting in a −57.92% surprise. The estimated earnings for the next quarter are −3.30 USD per share. See more details about Biora Therapeutics, Inc. earnings.
Biora Therapeutics, Inc. revenue for the last quarter amounts to ‪32.00 K‬ USD, despite the estimated figure of ‪210.00 K‬ USD. In the next quarter, revenue is expected to reach ‪115.00 K‬ USD.
BIOR net income for the last quarter is ‪−18.40 M‬ USD, while the quarter before that showed ‪6.46 M‬ USD of net income which accounts for −384.64% change. Track more Biora Therapeutics, Inc. financial stats to get the full picture.
No, BIOR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 58.00 employees. See our rating of the largest employees — is Biora Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biora Therapeutics, Inc. EBITDA is ‪−60.43 M‬ USD, and current EBITDA margin is ‪−1.66 M‬%. See more stats in Biora Therapeutics, Inc. financial statements.
Like other stocks, BIOR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biora Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biora Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biora Therapeutics, Inc. stock shows the sell signal. See more of Biora Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.